# Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.

> **NCT02014571** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 37 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** GSK2878175
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02014571
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-26
- **Primary completion:** 2014-07-03
- **Final completion:** 2015-01-15
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2018-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02014571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02014571, "Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02014571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*